Integrative prediction of Alzheimer's disease and related dementias using multi‐omics aging clocks and genetic data
Alzheimer's & Dementia · 2026-10 · 22 (10)
DOI: 10.1002/alz.71869 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Alzheimer's & Dementia, online erschienen am 28.09.2026. Verfasst von Shayan Mostafaei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Alzheimer Disease, Dementia, Multiomics, Aging. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, NIA NIH HHS, Loo and Hans Osterman Foundation.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION We tested whether combining Alzheimer's disease and related dementias (ADRD) polygenic risk scores (PRS) with biological aging markers improves ADRD risk prediction. METHODS In 16,215 UK Biobank (UKB) participants free of ADRD at baseline (median follow‐up: 10.08 years), 397 incident diagnoses were identified. Biological aging measures included clinical, telomere, proteomic, and metabolomic aging markers. External validation/replication was performed in TwinGene ( N = 3772; 331 cases). RESULTS The fully integrated model achieved area under the curve (AUC) = 0.90 and area under the precision‐recall curve (AUPRC) = 0.24 in the UKB held‐out test set. PRS was the strongest predictor (subdistribution hazard ratio [sHR] = 2.24, 95% CI: 2.02–2.48), followed by ProtAge (sHR = 2.01, 95% CI: 1.13–3.58). The top predicted‐risk quartile showed higher ADRD incidence (sHR = 16.73, 95% CI: 6.49–43.11). TwinGene showed moderate transportability (AUC = 0.757; AUPRC = 0.223) and preserved risk stratification (sHR = 4.02, 95% CI: 3.25–5.02). DISCUSSION Integrating PRS and biological aging measures improved ADRD risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
ORCID-Profile: Shayan Mostafaei
Förderung
- Swedish Research Council
- NIA NIH HHS
- Loo and Hans Osterman Foundation
- Karolinska Institutet Foundations
- Vetenskapsrådet
- National Institute on Aging
Zitieren
APA
Mostafaei, S., Gustavsson, K., Hagelin, H., Mak, J. K. L., Vu, T. N., Karlsson, I. K., & Hägg, S. (2026). Integrative prediction of Alzheimer's disease and related dementias using multi‐omics aging clocks and genetic data. Alzheimer's & Dementia, 22(10). https://doi.org/10.1002/alz.71869
Vancouver
Mostafaei S, Gustavsson K, Hagelin H, Mak JKL, Vu TN, Karlsson IK, et al. Integrative prediction of Alzheimer's disease and related dementias using multi‐omics aging clocks and genetic data. Alzheimer's & Dementia. 2026;22(10). doi:10.1002/alz.71869
BibTeX
@article{Mostafaei2026,
author = {Mostafaei, Shayan and Gustavsson, Karolina and Hagelin, Hampus and Mak, Jonathan K L and Vu, Trung Nghia and Karlsson, Ida K and Hägg, Sara},
title = {Integrative prediction of Alzheimer's disease and related dementias using multi‐omics aging clocks and genetic data},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {10},
doi = {10.1002/alz.71869}
}
EUVIMED